1-8 of 8
Matthew C Cheung, MD, SM
Close
Sort by
Journal Articles

Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan

Neil L Berinstein, MD, Nancy M Pennell, BSc, Rashmi Weerasinghe, Matthew C. Cheung, MD SM, FRCPC, Eugenia Piliotis, MD FRCP, MD, Kevin R Imrie, MD, Mary-Anne Cussen, Rena Buckstein, MD, Zeina Ghorab, Ellen Miles, Marciano D. Reis, MD
Journal: Blood
Blood (2016) 128 (22): 1794.
https://doi.org/10.1182/blood.V128.22.1794.1794
Published: 2016
Journal Articles

Assessment of Value Using the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) Frameworks for Novel Therapies for the Hematologic Malignancies

Matthew C Cheung, MD SM, FRCPC, Sierra Cheng, Erica McDonald, Vanessa Arciero, Mahin Qureshi, Kelvin Chan
Journal: Blood
Blood (2016) 128 (22): 3578.
https://doi.org/10.1182/blood.V128.22.3578.3578
Published: 2016
Journal Articles

Predictors for ICU Admission and Clinical Outcomes of Malignant Hematology Patients Admitted to Critical Care Units

Daniel Jacobson, BSc. (C), Nicholas Chiu, MD(C), Matthew C. Cheung, MD SM, FRCPC, Robert Fowler, MD MDM, M.Sc., Rena Buckstein, MD
Journal: Blood
Blood (2016) 128 (22): 3595.
https://doi.org/10.1182/blood.V128.22.3595.3595
Published: 2016
Journal Articles

Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Tanya Skamene, MD, Wenyu Jiang, PhD, Ralph M. Meyer, MD, Michael Crump, MD, John Kuruvilla, MD, C. Tom Kouroukis, MD MSc, FRCPC, Stefano Luminari, Stephen Couban, MD, Matthew C. Cheung, MD SM, FRCPC, David A Rizzieri, MD, Peter G Bardy, MBBS, FRACP, FRCPA, Joseph Pater, MD MSc, Marina S. Djurfeldt, MSc, Lois E. Shepherd, MD, Bingshu E Chen, PhD, Annette E Hay, MB ChB
Journal: Blood
Blood (2016) 128 (22): 690.
https://doi.org/10.1182/blood.V128.22.690.690
Published: 2016
Journal Articles

Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Long-Term Remission

Matthew C Cheung, MD SM, FRCPC, Nicole Mittmann, PhD, Craig Earle, MD MSc., Farah Rahman, Ning Liu, Simron Singh, MD MPH, FRCPC
Journal: Blood
Blood (2016) 128 (22): 692.
https://doi.org/10.1182/blood.V128.22.692.692
Published: 2016
Journal Articles

Azacitidine Use in the Real World Does Not Replicate AZA-001 Results in Higher Risk MDS/Low Blast Count AML: An Audit of 1101 Patients in the Cancer Care Ontario Registry

Lee Mozessohn, MD FRCPC, Matthew C. Cheung, MD SM, FRCPC, Saber Fallahpour, PhD, Tripat Gill, MSc PH, Asmaa Maloul, PhD, Liying Zhang, PhD, Olivia Lau, Rena Buckstein, MD
Journal: Blood
Blood (2016) 128 (22): 4338.
https://doi.org/10.1182/blood.V128.22.4338.4338
Published: 2016
Journal Articles

Publication Patterns of Cancer Cost-Effectiveness Studies Presented at the American Society of Hematology: Timeliness of Publication, Quality and Possible Bias.

Lee Mozessohn, MD, Kelvin KW Chan, MD, MSc, FRCPC, Matthew C Cheung, MD, SM, FRCPC
Journal: Blood
Blood (2010) 116 (21): 3816.
https://doi.org/10.1182/blood.V116.21.3816.3816
Published: 2010
Journal Articles

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Hatoon Ezzat, MD, Matthew C Cheung, MD, SM, Lisa K Hicks, MD, MSc, Kevin C Murphy, MD, Chantal S Leger, MD, Linda R Taggart, MD, Jordana Boro, Julio SG Montaner, MD, Marianne Harris, MD, Linda M Vickars, MD, Heather A Leitch, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2587.
https://doi.org/10.1182/blood.V112.11.2587.2587
Published: 2008